Safety-Based Drug Withdrawals
"Safety-Based Drug Withdrawals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.
| Descriptor ID |
D056737
|
| MeSH Number(s) |
I01.880.604.605.250.812 N04.452.706.310.750 N06.850.210.637.700
|
| Concept/Terms |
Safety-Based Drug Withdrawals- Safety-Based Drug Withdrawals
- Drug Withdrawal, Safety-Based
- Drug Withdrawals, Safety-Based
- Safety Based Drug Withdrawals
- Drug Withdrawals Due to Safety
- Safety-Based Drug Withdrawal
- Safety Based Drug Withdrawal
- Drug Withdrawal Due to Safety
|
Below are MeSH descriptors whose meaning is more general than "Safety-Based Drug Withdrawals".
Below are MeSH descriptors whose meaning is more specific than "Safety-Based Drug Withdrawals".
This graph shows the total number of publications written about "Safety-Based Drug Withdrawals" by people in this website by year, and whether "Safety-Based Drug Withdrawals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Safety-Based Drug Withdrawals" by people in Profiles.
-
Reduction in ephedra poisonings after FDA ban. N Engl J Med. 2015 May 28; 372(22):2172-4.
-
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.